URGN Return on Tangible Equity | UroGen Pharma Ltd.

UroGen Pharma Ltd. (URGN) Return on Tangible Equity

2026-06-30: Return Tang Equity 73.75%.
2026-03-31: Return Tang Equity 107.22%.
2025-12-31: Return Tang Equity 145.53%.
2025-09-30: Return Tang Equity 142.66%.

Complete source-backed return tang equity history.

Available history: 2015-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	73.75%
2026-03-31	107.22%
2025-12-31	145.53%
2025-09-30	142.66%
2025-06-30	165.96%
2025-03-31	297.97%
2024-12-31	1441.26%
2024-09-30	-452.20%
2024-06-30	-374.69%
2024-03-31	259.92%
2023-12-31	156.79%
2023-09-30	250.27%
2023-06-30	78.77%
2023-03-31	95.75%
2022-12-31	122.85%
2022-09-30	172.81%
2022-06-30	278.02%
2022-03-31	663.45%
2021-12-31	-1317.25%
2021-09-30	-357.97%
2021-06-30	-198.15%
2021-03-31	-152.47%
2020-12-31	-133.34%
2020-09-30	-113.61%
2020-06-30	-91.38%
2020-03-31	-80.75%
2019-12-31	-58.32%
2019-09-30	-42.62%
2019-06-30	-39.23%
2019-03-31	-34.94%
2018-12-31	-83.98%
2018-09-30	-59.88%
2018-06-30	-36.80%
2018-03-31	-24.19%
2017-12-31	-29.19%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	145.53%
2024-12-31	1441.26%
2023-12-31	156.79%
2022-12-31	122.85%
2021-12-31	-1317.25%
2020-12-31	-133.34%
2019-12-31	-58.32%
2018-12-31	-83.98%
2017-12-31	-29.19%
2016-12-31	-11.90%
2015-12-31	-77.94%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Nuvation Bio Inc. (NUVB)	United States	$2.007B	-13.12
NEKTAR THERAPEUTICS (NKTR)	United States	$2.026B	-9.05
PERRIGO Co plc (PRGO)	Ireland	$2.038B	-0.79
Biohaven Ltd. (BHVN)	United States	$1.990B	-3.83
Generate Biomedicines, Inc. (GENB)	United States	$2.052B
AGIOS PHARMACEUTICALS, INC. (AGIO)	United States	$1.962B	-5.38
Sarepta Therapeutics, Inc. (SRPT)	United States	$1.941B	-13.89
Trevi Therapeutics, Inc. (TRVI)	United States	$2.091B	-51.93
PALVELLA THERAPEUTICS, INC. (PVLA)	United States	$2.105B	-35.55
Braveheart Bio, Inc. (BRVE)	United States	$2.106B